Previous Image
Next Image

Intellectual Property

Avipep held a worldwide patent estate on diabodies, notably US5844094 and EP1005494, based on the original inventive molecular designs to produce Avibodies. (PCT AU93/00491 and AU98/00212).

Avipep expanded this estate with two worldwide patents “Immunoconjugates and methods of producing them” for the design and production of V-domains in antibodies and “antibody fragments with surface disulphides for loading therapeutic and diagnostic payloads” (PCTs AU2010/000847 and AU2010/001737). These patents are granted in USA 61/223,353 and 61/289,497 and in EU 10838426.4 and 10793442.4